Celladon Corp (CLDN)

19.77
0.50 2.59
NASDAQ : Health Care
Prev Close 19.27
Open 19.13
Day Low/High 19.00 / 19.89
52 Wk Low/High 12.90 / 28.35
Volume 22.76K
Avg Volume 10.50K
Exchange NASDAQ
Shares Outstanding 1.59M
Market Cap 27.50M
EPS -27.30
P/E Ratio N/A
Div & Yield N.A. (N.A)
Jim Cramer -- Stay Bullish on Netflix, Learn From Celladon

Jim Cramer -- Stay Bullish on Netflix, Learn From Celladon

TheStreet's Jim Cramer agrees with analysts on Netflix and says Celladon is an example of 'biotech FDA roulette.'

Stocks Post Modest Gains; Apple Jumps Ahead of Earnings

Stocks Post Modest Gains; Apple Jumps Ahead of Earnings

Stocks are moving higher on Monday, adding to record highs for the S&P 500 and Nasdaq achieved on Friday.

Gene Therapy Stocks on Watch Following Failure of Celladon's Heart Failure Trial

Gene Therapy Stocks on Watch Following Failure of Celladon's Heart Failure Trial

Will the failure of Celladon's Mydicar gene therapy bring other high-flying gene therapy stocks down to Earth?

Celladon Enters Oversold Territory (CLDN)

Celladon Enters Oversold Territory (CLDN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

5 Stocks Set to Soar on Bullish Earnings

5 Stocks Set to Soar on Bullish Earnings

These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.

Celladon To Report Fourth Quarter And Fiscal 2014 Results On March 31

Celladon To Report Fourth Quarter And Fiscal 2014 Results On March 31

Investor Call Scheduled for 8:30am Eastern on Tuesday, March 31, 2015

Celladon Heart-Failure Study Looms Large as Next Big Test for Gene Therapy

Celladon Heart-Failure Study Looms Large as Next Big Test for Gene Therapy

In April, Celladon is expecting results from a mid-stage study of a gene therapy aiming to improve the pumping ability of the heart in patients with advanced heart failure.

'Mad Money' Lightning Round: Buy, Buy, Buy Whole Foods Markets

'Mad Money' Lightning Round: Buy, Buy, Buy Whole Foods Markets

Cramer likes Celladon and Sirius XM Radio, thinks Centene is amazing and is avoiding King Digital and Virgin America.

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

Cramer says it's time to take some profits and raise cash for the next speed bump. He'll be watching company earnings from Sonic, Paychex and GameStop, among others.

Rite Aid Rallies on EnvisionRx Acquisition

Rite Aid Rallies on EnvisionRx Acquisition

Rite Aid Corporation (NYSE:RAD), USA Truck Inc. (NASDAQ:USAK) and Celladon Corp. (NASDAQ:CLDN) made big morning gains this Wednesday. AOL Inc. (NYSE:AOL), Seventy Seven Energy Inc. (NYSE:SSE) and Inte...

14 IPOs You Wish You Bought in 2014 (and Made a Killing On)

14 IPOs You Wish You Bought in 2014 (and Made a Killing On)

Getting in on a hot IPO may prove difficult for most retail investors. That doesn't mean there aren't gains to be made. Here are the best performing IPOs in 2014.

These 3 Gold Stocks Climbed Over 11% Today

These 3 Gold Stocks Climbed Over 11% Today

Today's gold rally resulted in climbs for Kinross Gold Corporation (NYSE:KGC), Yamana Gold Inc. (NYSE:AUY) and AuRico Gold Inc. (NYSE:AUQ). CHC Grop Ltd. (NYSE:HELI), Celladon Corp. (NASDAQ:CLDN) an...

Celladon Corporation Conducts Initial Scale Up Of Manufacturing Process For MYDICAR To Commercial Scale

Celladon Corporation Conducts Initial Scale Up Of Manufacturing Process For MYDICAR To Commercial Scale

2,000L Demonstration Batch Completed at Lonza, Houston Facility

Energy Spinoffs Transocean Partners, Seventy Seven Energy Tumble

Energy Spinoffs Transocean Partners, Seventy Seven Energy Tumble

Sears Hometown and Outlet Stores Inc (NASDAQ:SHOS), Celladon Corp (NASDAQ:CLDN) and Repros Therapeutics Inc (NASDAQ:RPRX) are gaining this Monday. Gulf Coast Ultra Deep Royalty Trust (NASDAQ:GULTU),¿...

Celladon Corporation To Present At Credit Suisse Healthcare Conference

Celladon Corporation To Present At Credit Suisse Healthcare Conference

Now Presenting November 12 at 11:30 am MST

Celladon Corporation Announces Publication Of Data From Its Stem Cell Factor Gene Therapy Program In Circulation Heart Failure

Celladon Corporation Announces Publication Of Data From Its Stem Cell Factor Gene Therapy Program In Circulation Heart Failure

New Gene Therapy Approach Shown to Reverse Heart Damage and Improve Long Term Cardiac Function Following Myocardial Infarction in Animal Models